Fidelity International’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-168,786
Closed -$3.38M 867
2021
Q3
$3.38M Sell
168,786
-109,191
-39% -$2.82M ﹤0.01% 646
2021
Q2
$8.58M Hold
277,977
0.01% 574
2021
Q1
$7.13M Buy
277,977
+110,491
+66% +$2.77M 0.01% 560
2020
Q4
$2.68M Sell
167,486
-167,148
-50% -$2.06M ﹤0.01% 600
2020
Q3
$4.08M Buy
+334,634
New +$4.83M 0.01% 551

Other funds holding RNLX

Fidelity International's RNLX Position: Q4 2021 in Review

Fidelity International sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2021, closing a stake of 168,786 shares — an estimated $3.38M sold.

Fidelity International first reported a position in RNLX in Q3 2020 and held it in 5 quarters. The position peaked at $8.58M in Q2 2021. 33 funds tracked by Wall St. Rank hold RNLX as of Q4 2021.

  • Fidelity International reported no remaining Renalytix plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Fidelity International sold 168,786 Renalytix plc American Depositary Shares shares in Q4 2021, an estimated $3.38M.
  • Fidelity International first reported a position in Renalytix plc American Depositary Shares in Q3 2020 and held it in 5 quarters.
  • Fidelity International's Renalytix plc American Depositary Shares position peaked at $8.58M in Q2 2021.
  • 33 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2021.

Based on Fidelity International's 13F filing for Q4 2021, filed 14 Feb 2022.